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Arabinogalactan proteins (AGPs) are abundant extracellular proteoglycans that are found in most plant species and involved in
many cellular processes, such as cell proliferation and survival, pattern formation, and growth, and in plant microbe interaction.
AGPs are synthesized by posttranslationalO-glycosylation of proteins and attached glycan part often constitutes greater than 90%of
the molecule. Subtle altered glycan structures during development have been considered to function as developmental markers on
the cell surface, but little is known concerning the molecular mechanisms. My group has been working on glycosylation enzymes
(glycosyltransferases) of AGPs to investigate glycan function of the molecule. This review summarizes the recent findings from
my group as for AtGalT31A, AtGlcAT14A-C, and AtGalT29A of Arabidopsis thaliana with a specific focus on the (i) biochemical
enzyme activities; (ii) subcellular compartments targeted by the glycosyltransferases; and (iii) protein-protein interactions. I also
discuss application aspect of glycosyltransferase in improving AGP-based product used in industry, for example, gum arabic.
1. Introduction
Arabinogalactan proteins (AGPs, AG proteins) are plant-
specific proteoglycans that are found in most of the analyzed
plant species. The main component of AGPs is AG glycan,
which often constitutes greater than 90% of the molecule.
Studies using monoclonal antibodies recognizing different
epitopes of AG glycans have demonstrated a temporal and a
spatial appearance of certain subpopulations of AG glycans
during plant development (for review, see [1]). In animal cells,
the structural diversities of cell-surface proteoglycans under-
lie their various functions, for example, interaction with hor-
mone, extracellular matrix components, and enzymes, and
play an important role in signal transduction and/or cell-cell
communication and adhesion (for review, see [2]). Analogous
mode of action is expected for a specific AG subpopulation
during plant development, but little is known regarding the
molecular mechanisms. My group has been working on the
biosynthetic enzymes of AG glycans to understand the devel-
opmentally regulated biosynthesis of AG glycans.
AG glycans are synthesized on core proteins by posttrans-
lational modifications (O-glycosylation).The structure of AG
glycans is complex and heterogeneous, changes throughout
development, and commonly consists of 𝛽-1,3-linked galac-
tans as main chains that are substituted with various lengths
of 𝛽-1,6-galactan side chains, which are further decorated by
arabinose and other sugars, such as (methyl) glucuronic acid
(GlcA), rhamnose, and fucose. Glycosylation is catalyzed by
large number of glycosyltransferases (GTs) in the secretory
pathway.
To date, two 𝛼-1,2-fucosyltransferases (AtFUT4 and
AtFUT6) [3], three galactosyltransferases (AtGALT2, At-
GALT31A, and AtGALT29A) [4–6], and three glucurono-
syltransferases (AtGlcAT14A, B, and C) [7, 8], all from Ar-
abidopsis thaliana, have been characterized (for review, see
[9]). The mutation in the RAY1 gene leads to a reduction
in the arabinose residues in AGPs [10] and, as expected,
encodes the activity of arabinosyltransferase. However, the
recombinant protein made 𝛽-linked arabinose instead of
𝛼-linked arabinose that is present in AGPs; therefore, the
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Figure 1: Screening of glycosyltransferase activities. Recombinant protein is tested for glycosyltransferase activity in the presence of broad
range of donor-substrates and acceptor-mixture (1). Acceptor molecule is identified by analyzing the product made on the acceptor-mixture
in (1) by testing susceptibility to structure-specific hydrolases and/or testing structure-defined oligosaccharides for the glycosyltransferase
activity (2).
involvement of this enzyme in the arabinosylation of AGPs
seems not as direct as 𝛼-arabinosyltransferase.
Among thoseGTs that are listed above, we have character-
ized AtGalT31A, AtGalT29A, AtGlcAT14A, AtGlcAT14B, and
AtGlcAT14C. We took a cross-disciplinary approach to char-
acterize the biochemical properties of the enzymes and their
cell biological aspects and used basic research to advance
towards a more biotechnological application of the enzymes.
This review summarizes the main research outcomes from
my group and discusses future perspectives in this research
field.
2. Main Text
2.1. Identification and Biochemical Characterization of Ara-
binogalactan Glycosyltransferases from Arabidopsis thaliana.
GTs are difficult enzymes to characterize because (i) these
enzymes are generally expressed at low levels, (ii) redundant
activities mask the mutant phenotype, and (iii) pleiotropic
effects confuse the relationship between the mutant phe-
notype and the enzyme activity that is encoded by the
mutated gene. It reflects the fact that enzyme activities that are
encoded by approximately 20 genes have biochemically been
characterized in Arabidopsis thaliana, among more than 450
putative GTs that have been deposited into the carbohydrate
active enzyme database (CAZy, http://www.cazy.org/).
We have used a forward genetics approach for putative
GTs from Arabidopsis thaliana, taking advantage of the com-
pleted genome sequencing in 2001 and availability of a large
amount of -omics data for this species. Because AG is a
unique structure in plants and it is difficult to predict GT
candidates from the primary sequences, we developed a
screening method for GTs that are related to AG biosynthesis
(illustrated in Figure 1). First, we prepared a heterogeneous
mixture of various AG oligosaccharides from microsomes
after expressing AGP synthetic peptides in tobacco leaves.
Using the AG acceptor-mixture, wemeasured the GT activity
from wide range of 14[C]-labeled donor-substrates. Next, we
attempted to identify acceptor molecules by analyzing sus-
ceptibility of the resulted 14[C]-sugar-incorporated products
by structure-specific hydrolases or by testing the structure-
defined oligosaccharides as acceptors.There are several avail-
able AG-specific hydrolases, for example, endo-𝛽-1,6-galac-
tanase, exo-𝛽-1,3-galactanase, 𝛼-arabinofuranosidase, 𝛽-glu-
curonidase, and 𝛼-rhamnosidase, which are extremely useful
when analyzing the AG products (for review, see [9]).
Using thismethod, we identifiedAtGalT31A, AtGalT29A,
and AtGlcAT14A, 14B, and 14C as AG GTs.
AtGALT31A, which is encoded by At1g32930, was identi-
fied as a galactosyltransferase that is involved in elongating
the 𝛽-1,6-galactan of the AG side chains [5]. The soluble
catalytic domain expressed in E. coli and the full-length
protein expressed in N. benthamiana demonstrated a trans-
fer of 14[C]-Gal from UDP-14[C]-Gal to the heterologous
mixture of AG acceptors. The 14[C]-incorporated products
were susceptible to the treatment of endo-𝛽-1,6-galactanase
and resulted in 14[C]-galactose and 14[C]-galactobiose but
were not susceptible to the exo-𝛽-1,3-galactanase treatment.
These results indicate that the transferred 14[C]-Gal was a
part of 𝛽-1,6-galactan, which is longer than galactotriose,
and that this enzyme acts to elongate 𝛽-1,6-galactan but
not 𝛽-1,3-galactan. The mutation of this gene resulted in
an embryo-lethal phenotype (see below), and we could not
confirm the in vivo effect of the AG structure by knocking
out this gene.We named the enzymeAtGalT31A (Arabidopsis
thaliana galactosyltransferase from family 31).
AtGlcAT14A (At5g39990) and AtGalT29A (At1g08280)
were coexpressed with AtGalT31A (At1g32930) (GeneCAT
[12]), andwe selected as candidateGTs that are involved in the
biosynthesis of AG. We investigated the encoding activities
of these GTs by heterologous expression and in vitro enzyme
assays as were performed in the study of AtGalT31A.
The soluble catalytic domain of AtGlcAT14A (At5g39990)
expressed in Pichia pastoris demonstrated a transfer of 14[C]-
GlcA from UDP-14[C]-GlcA to both 𝛽-1,3- and 𝛽-1,6-linked
galactooligosaccharides [7]. A mutant analysis revealed a
reduction of the corresponding structure in isolated AG (see
below), indicating that this is enzyme responsible for the
addition of GlcA to the terminal 𝛽-1,6-galactan side chains
and of a single GlcA to the 𝛽-1,3-galactan main chain of AG.
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We named the enzyme AtGlcAT14A (Arabidopsis thaliana
glucuronic acid transferase from family 14).The CAZy family
GT14 contains 11 proteins, including AtGlcAT14A. When we
analyzed the recombinant proteins for all of the 11 isoforms,
At5g15050 and At2g37585 also demonstrated glucuronosyl-
transferase activity by adding GlcA to 𝛽-1,3- and 𝛽-1,6-linked
galactans [8].Therefore, we named At5g15050 and At2g37585
as AtGlcAT14B and AtGlcAT14C, respectively.
ForAtGalT29A (At1g08280), we expressed the full-length
protein in Nicotiana benthamiana and demonstrated a trans-
fer of 14[C]-Gal from UDP-14[C]-Gal to a mixture of AG
acceptors [6]. The products were susceptible to endo-𝛽-1,6-
galactanase, and the release of small oligosaccharides was
promoted by cotreatment with 𝛼-arabinofuranosidases. This
result indicates that the incorporated 14[C]-Gal was a part
of 𝛽-1-6-galactooligosaccharides that were longer than galac-
totriose with and without the substitution of arabinose. The
14[C]-incorporated product was also susceptible to exo-𝛽-1,3-
galactanase, and the treatment released 14[C]-disaccharide
but not 14[C]-monosaccharide, indicating that the enzyme
activity on 𝛽-1,3-galactan is a 6-14[C]-Gal branch-forming
activity rather than a 𝛽-1,3-galactan elongating activity.Thus,
AtGALT29A possesses 𝛽-1,6-GalT activity elongating 𝛽-1,6-
galactan and making branches on 𝛽-1,3-galactan, and we
named the enzyme AtGalT29A (Arabidopsis thaliana galac-
tosyltransferase from family 29).
We found that AtGALT29A forms a protein complex with
AtGALT31A when expressed ectopically in N. benthamiana
and that the enzyme complex exhibited an increased level of
𝛽-1,6-GalT activity as described above compared to the single
AtGALT29A (the details are described below). Additionally,
a proteomics analysis identified phosphorylated Y144, and
a site-directed mutagenized construct on Y144 affected the
subcellular targeting and enzyme activity of AtGALT29A (the
details are described below).
2.2. Mutant Analysis. A T-DNA insertional mutant of
At1g32930 (AtGalT31A) was embryo-lethal [5]. In the embryo
proper, the AtGALT31A mRNA was specifically located in
the suspensor, while abnormal cell division was observed in
the hypophysis during the globular stage of the embryo in
the atgalt31a mutant lines. The atgalt31a mutants arrested
further development of the embryo proper, which resulted in
the embryo-lethal phenotype. Thus, functional AtGALT31A
is essential for normal embryo development. However, how
the spatially distant expression of AtGALT31A in the suspen-
sor influences the cell division in the hypophysis remains
unknown.
A T-DNA insertionalmutant ofAt5g39990 (AtGlcAT14A)
exhibited an increased elongation rate during seedling
growth under both light and dark conditions [7]. In the
isolated AG from the atglcat14a lines, the level of GlcA
substitution on both the 𝛽-1,6-galactan side chains and 𝛽-1,3-
galactan main chains was reduced. Moreover, we observed
an increase in the 3-, 6-, and 3,6-linked Gal and a decrease
in the 2-, 3-, 5-, and 2,5-linked Ara in the mutant AG. We
interpreted the increase in the 6- and 3,6-Gal linkages as
a result of the increased availability of O6 in both 𝛽-1,3-
linked and 𝛽-1,6-linked Gal for elongation of galactans due
to the reduction in the activity of AtGlcAT14A, since both
enzymes act on the same acceptor site of Gal. An apparent
reduction of Ara might be seen if the amount of Ara was
unchanged while elongating 𝛽-1,6-galactan when the sugar
levels were calculated as mol% relative to the total amount,
but this hypothesis remains to be elucidated.
An analysis of knock-out mutants for At1g08280 (At-
GALT29A), At5g15050 (AtGlcAT14B), and At2g37585 (At-
GlcAT14C) is underway. It has been suggested that the GlcA
residues on the AG side chains bind to extracellular calcium
and play roles as Ca capacitors [13] and that AG GlcAT
activities may be important to guarantee GlcA residues in
the AGPs. Calcium plays a central role in cell elongation and
growth in plants. We did not observe a detectable growth
phenotype in atglcat14a in addition to the enhanced cell
elongation in the seedlings [7], but obviously AtGlcAT14B
and C likely have redundant activities with AtGlcAT14A in
plants [8]. Therefore, it is necessary to investigate double and
triple mutants to understand the role of the GlcA residues in
AG glycans.
2.3. Protein-Protein Interactions between AtGALT29A and
AtGALT31A Result in Increasing 𝛽-1,6-Galactosyltransferase
Activities. In mammalian cells, it is well known that enzymes
that are involved in protein glycosylation interact with each
other and form “assembly lines” in the secretory pathway
[14]. We, therefore, investigated the protein-protein interac-
tions among AtGALT31A, AtGALT29A, and AtGLCAT14A
that were ectopically expressed as C-terminally fluorescent-
labeled constructs inN. benthamiana by analyzing the Fo¨rster
resonance energy transfer (FRET) between the fluorescent
donor and acceptor proteins [6]. We established the acceptor
photobleaching FRET method to study the protein-protein
interactions between GTs tagged with mCer3 (donor fluo-
rophore, monomeric cyan fluorescent protein 3) and YFP
(acceptor fluorophore, yellow fluorescent protein) that reside
in the Golgi apparatus by stop cytoplasmic streaming by an
inhibitor for actin polymerization, Cytochalasin D (CytD)
[15]. The pixel-by-pixel FRET efficiencies were calculated by
[16] using the ImageJ [17] plug-in. Because the 0 scale is
set for the FRET efficiency obtained from the donor-only
control, any values greater than 0 indicate a close proximity
of less than 10 nm and, thus, the presence of a protein-protein
interaction [16].
Using this method, we demonstrated interactions be-
tween AtGALT29A-mCer and AtGALT29-YFP (homodim-
er), AtGALT31A-mCer and AtGALT31A-YFP (homodimer),
and AtGALT29A-mCer (or -YFP) and AtGALT31A-YFP
(or -mCer) (heterodimer) [6]. However, there were no in-
teractions between a combination of AtGALT31A-mCer3
and AtGlcAT14A-YFP [7]. The FRET efficiency between
AtGAL29A and AtGLCAT14A was greater than 0 (13%, [6]),
but these two proteins often do not colocalize, suggest-
ing that this interaction is likely less important than the
interactions that were found between AtGALT29A and
AtGALT31A, in which two proteins colocalize at a high
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frequency. Furthermore, based on the level of the FRET
efficiencies, it has been suggested that (i) AtGALT31A is less
capable of forming dimers than is AtGALT29A and (ii) the
heterodimer between AtGALT29A and AtGALT31A is the
preferred form when both AtGALT29A and AtGALT31A are
available, and we anticipate the preferred forms of GTs in
the following order: AtGALT29A/AtGALT31A heterodimer,
AtGALT29A homodimer, AtGALT31A homodimer, and
AtGALT31A monomer [6].
We could purify the protein complex containing both
AtGALT29A and AtGALT31A by coimmunoprecipitation
using an epitope tag of one of the recombinant proteins [6].
The singly expressed recombinant protein of AtGALT31A
and AtGALT29A possess 𝛽-1,6-GalT activity elongating 𝛽-
1,6-galactan (AtGALT29A also possesses 𝛽-1,6-GalT activity
adding single 6-Gal to 𝛽-1,3-galactan) at low levels, but the
protein complex containing AtGALT29A and AtGALT31A
demonstrated an increased level of 𝛽-1,6-GalT activities both
elongating 𝛽-1,6-galactan and adding single 6-Gal to 𝛽-
1,3-galactan compared to the AtGALT29A or AtGALT31A
single enzyme. According to the FRET data, it is conceivable
that AtGALT29A and AtGALT31A are present as a het-
erodimer in the coimmunoprecipitated sample, while they
are present as homodimers when they are expressed alone.
The results indicated a cooperative action of AtGALT29A
and AtGALT31A by forming a heterodimer. It is conceivable
that the protein-protein interaction can more rapidly adapt
to the environment compared to the transcriptional controls.
𝛽-1,6-Galactan is detected specifically in the tips of the root
hair by a specific antibody [18]; therefore, the interaction
between AtGALT29A and AtGALT31Amay contribute to the
specific appearance of the 𝛽-1,6-galactan side chains of AG in
such a limited portion of tissues during plant development.
The investigation of other GTs that are involved in the AG
biosynthetic pathway should address the importance of the
role of protein-protein interactions in the biosynthesis of AG
glycans.
2.4. Arabinogalactan Glycosyltransferases Target Uncharacter-
ized Subcellular Compartments Which May Be a Part of an
Unconventional Protein Secretion Pathway. When we inves-
tigated the subcellular localization of AG GTs by the ectopic
expression of C-terminal fluorescence-fusion proteins in N.
benthamiana, we found that AG GTs are localized not only
to the Golgi apparatus (∼1.0 𝜇m diameter) but also to yet
uncharacterized smaller compartments (∼0.5 𝜇m diameter)
[11] (Figure 2). All three of the studied AGGTs (AtGALT31A,
AtGALT29A, and AtGlcAT14A) showed dual localization in
the Golgi and these small compartments, but AtGALT31A
was frequently localized to the small compartments (∼80%
of the total AtGALT31A population when expressed in N.
benthamiana). However, the N-glycosylation enzymes (N-
acetylglucosaminyltransferase I, GnTI; 𝛼-mannosidase II,
GMII; and sialyltransferase, ST) were almost all localized
to the Golgi and were rarely found in the small compart-
ments where AtGALT31A was localized. Therefore, the small
compartments appeared to be rather dedicated to a portion
of AG biosynthesis but not to N-glycan processing. This
Figure 2: The AtGALT31A-mCer3-localized small compartments
(cyan) and the mannosidase II-mRFP-localized Golgi cisternae
(magenta) when transiently expressed in N. benthamiana leaves.
Scale bar = 1 𝜇m.
organization is different from that of mammalian cells, in
which both the N- and O-glycosylation enzymes are located
in the Golgi but are separated by forming protein complexes
within the pathway but not across the pathways [19]. Consid-
ering the presence of more than twice of glycosyltransferases
in plants (e.g., more than 450 from Arabidopsis thaliana
in CAZy database) than in mammals (e.g., approximately
200 from Homo sapiens in CAZy database), plant cells most
likely have evolvedmultiplemanagement systems to organize
the many different glycosylation processes, which not only
form protein complexes within the pathway (protein-protein
interactions across the pathways have not been studied in
plants) but also localize the pathway in a spatially different
organelle.
The AtGALT31A-localized small compartments are of a
similar size as the trans-Golgi network (TGN) defined by
SYP61, but AtGALT31A did not colocalize with SYP61 [11].
Additionally, the AtGALT31A-localized small compartments
did not colocalize with the FM4-64-stained early endo-
some [11]. Instead, AtGALT31A partially colocalized with
EXO70E2, a newly identified marker for an exocyst-positive
organelle (EXPO) that is present in Arabidopsis and tobacco
cells [20]. The EXPO represents an unconventional secretory
pathway (UPS) in plants, apart from the conventional secre-
tory pathway from the ER, the Golgi apparatus, and the TGN
to the plasma membrane (for review, see [21]).
The AtGALT31A-localized small compartments were
rather insensitive to the treatments of Brefeldin A and
Wortmannin [11], two well-known inhibitors of different
parts of vesicle trafficking in the secretory pathway. This
feature has also been observed in EXPO as evidence of
being a Golgi-independent pathway [20]. The overall results
implicate the AtGALT31A-localized small compartments as
distinct from the Golgi, SYP61-localized TGN, FM4-64-
stained early endosomes, and Wortmannin-vacuolated pre-
vacuolar compartments but as most likely a part of UPS
pathway together with EXPO in plants.
2.5. The Replacement of Tyrosine 144 by Other Amino Acids
and Coexpression with AtGALT31A Effects on Subcellular
Targeting of AtGALT29A. Proteomics studies identified the
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Table 1: AtGALT29A with or without the mutagenesis of Y144. 1Interaction with AtGALT31A as analyzed by FRET acceptor photobleaching
[6, 11]; the numbers in brackets indicate the FRET efficiencies; 2frequency (%) of the subcellular targeting of the small compartments of
∼0.5 𝜇m in diameter when the construct was expressed solely or coexpressed with AtGALT31A [11]; the numbers in brackets indicate the
colocalization frequency with AtGALT31A within the small compartments.
Interaction with AtGALT31A1 Localization to small compartments
2
Expressed solely Coexpressed with AtGALT31A
AtGALT29A Yes (18%) 25% 39% (38%)
Y144A Yes (9%) 60% 79% (66%)
Y144E Yes (10%) 70% 66% (64%)
phosphorylated Tyr at 144 (Y144) on a peptide that was
derived from AtGALT29A [22], and we investigated the
significance of Y144 by replacing Y144 with A or E (Y144A
and Y144E, resp.) by site-directed mutagenesis. AtGALT29A
possesses approximately 10 possible phosphorylation sites
in its sequence; however, the Y144 is the only site where
the phosphorylation has been detected. The predicted 3D
structure indicates that the Y144 site is located in the periph-
eral surface of the globular catalytic domain of AtGALT29A.
Other GTs, for instance, AtGALT31A, do not possess a Tyr in
the corresponding position.
Subcellular targeting was affected by the Y144A
and Y144E mutagenesis of recombinant AtGALT29A.
AtGALT29A without mutagenesis localizes approximately
25% of the whole population to the small compartments of
∼0.5 𝜇m diameter, while the targeting frequency increased
to 60% and 70% in the Y144A and Y144E constructs,
respectively, when expressed transiently in N. benthamiana
[11] (Table 1). Because bothmutageneses showed an increased
frequency of targeting to the small compartments, Y144 itself
appeared to play a role in determining the subcellular
targeting rather than the electrostatic status of Y144.
The subcellular distribution of AtGALT29A also changed
when the construct was expressed solely or coexpressed with
the interaction partner AtGALT31A. The results that are
described above are from the sole expression of the respec-
tive construct in N. benthamiana. When these constructs
were coexpressed with AtGALT31A, targeting to the small
compartments increased from 25% to 40% in AtGALT29A
and from 60% to 79% in AtGALT29A Y144A, while the
distribution of Y144E in the small compartmentswas roughly
the same or slightly decreased to 66% compared to when
expressed alone (70%) [11] (Table 1). We suspected that the
increased targeting to the small compartments was due
to the increased interaction with AtGALT31A; however,
the FRET efficiencies between AtGALT31A-mCer3 and
AtGALT29A Y144A-YFP or Y144E-YFP were lower (9% and
10%, resp., [11]) than the value between AtGALT31A-mCer3
and AtGALT29A-YFP (18%) [6] (Table 1). Therefore, Y144A
and Y144E appeared less capable of forming a heterodimer
with AtGALT31A than the unmodified AtGALT29A, and it is
unlikely that the increased targeting of Y144A and Y144E to
the small compartments was led by an increased interaction
with AtGALT31A. Currently, we do not know the factors
controlling the subcellular targeting of AtGALT29A Y144A
or Y144E.
Taken together, Y144 appears to be important in deter-
mining the subcellular distribution of AtGALT29A andwhen
both AtGALT29A and AtGALT31A are present, the two
proteins most likely interact and increase their localization
to the small compartments. When AtGALT29A forms a
complex with AtGALT31A, the protein complex exhibits an
increased level of GalT activity compared to that of the
AtGALT29A single enzyme [6]. We have preliminary data
demonstrating an increase in the GalT enzyme activity in
the recombinant Y144A protein and a decreased activity in
the recombinant Y144E protein compared to the level of
AtGALT29A activity without mutagenesis. Therefore, it is
interesting to investigate the relationships between (i) the
charge status of Y144 and (ii) the heterodimer formation
with AtGALT31A and whether these factors work additively,
synergistically, or antagonistically in controlling the GalT
activity of AtGALT29A.
2.6. Gum Arabic Harboring an Increased Amount of GlcA by
the In Vitro Action of AtGlcAT14A Improved the Emulsifier
Property. Gum arabic is the exudate of Acacia senegal and
Acacia seyal produced upon wounding and is used widely
as a food additive (E414 in Europe, GRAS in FDA in
USA). Because gum arabic does not form a viscous solution
up to quite high concentrations (Newtonian flow up to
40% (w/v)), this product is particularly superior as an oil-in-
water emulsifier in the beverage area. Gum arabic is amixture
of heterogeneous substances, of which AGP is essential for
its function as an emulsifier by having both hydrophobic
protein and hydrophilic carbohydrate portions that interact
with oil droplets and aqueous solutions, respectively [23].The
carbohydrate portions of gum arabic are believed to provide a
strong steric barrier against the flocculation and coalescence
of oil-in-water emulsions [24, 25].
Because we found that the commercial gum arabic
(Sigma-Aldrich) serves as a good acceptor for the reaction of
AtGlcAT14A (GlcA was incorporated from UDP-GlcA up to
1/3 of the total gum arabic weight), we characterized the oil-
in-water emulsions of the modified gum arabic by the action
ofAtGlcAT14A and compared these emulsions to unmodified
gum arabic. We found that the oil-in-water emulsions that
were made by the enzyme-modified gum arabic were slightly
smaller in size and remarkably more stable compared to the
emulsions that were made by the unmodified gum arabic
[26]. This result is likely due to the additionally incorporated
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GlcA by the action of AtGlcAT14A providing extra charges to
the carbohydrate surface of the oil-in-water emulsions that
are mediated by gum arabic, likely resulting in an increase
of the electrical repulsion of each emulsion and preventing
interactions between each other, leading to flocculation and
coalescence. Thus, this modification appears promising for
improving the emulsifier property of gum arabic.
2.7. Conclusions and Future Perspectives. We have charac-
terized the arabinogalactan glycosyltransferases AtGALT31A,
AtGLCAT14A, and AtGALT29A (later also AtGlcAT14B and
C) for their biochemical enzyme activities and cell biological
aspects of the proteins (protein-protein interactions, subcel-
lular targeting, etc.) and have provided novel insight into our
understanding of AGP biosynthesis. Heterodimer formation
between AtGALT31A and AtGALT29Amay be a rapid way to
respond to a requirement of the synthesis of 𝛽-1,6-galactan
andmight be a regulatorymechanism to serve subtly changed
AG glycans during plant development. The importance of
such systems working in other GTs in AGP glycosylation
remains to be elucidated. Furthermore, we identified small
subcellular compartments that are uniquely targeted by
AG GTs (protein O-glycosylation) but not by protein N-
glycosylation enzymes.This result suggests a different level of
organization of O- and N-glycosylation enzymes in plants
compared to that in mammalian cells, most likely a result of
the adaptation to a large number of glycosylation processes in
plants, for example, by the presence of cell walls.Moreover, we
found an overlapwith the EXPO and the small compartments
based on a colocalization study and suggested a possibility of
the small compartments being involved in an unconventional
protein secretion pathway. EXPO is uniquely composed of
double membranes and releases inner single-membrane-
bound vesicles into the extracellular space after the outer
membrane fuses to the plasma membrane [20]. EXPO may
serves an attractive alternative transport system and glycosy-
lation localization in addition to the conventional secretory
pathway through the Golgi apparatus, which has been used
to produce recombinant glycoconjugates by now. It is well
known that the subcellular localization of the glycosylation
is necessary to investigate the detailed domain architectures
of the proteins that reside in the small compartments and
EXPO for future applied research, for example, to produce a
foreign (glycosylated) peptide to be excreted outside of the
cells. If we have knowledge of the domains defining the
subcellular targeting and the domains that are involved
in protein-protein interactions, we could manipulate the
glycan structure by domain swapping (successful examples
described in a review in [27]). A suspension cell culture
system is worth investigating as a candidate host because
these cells naturally produce AGPs in a very large amount
and secrete AGPs to the medium [28]; therefore, these cells
should serve a good base for further genetic engineering.
GTs aremost likely not the traditional industrial enzymes
for use in in vitro reactions because they require an expensive
donor-substrate (NDP-sugar). However, an in vivo approach
(metabolic engineering) may be a promising approach to
modify the glycan structure of useful glycoconjugates. We
have shown that the additional GlcA incorporation to gum
arabic by the in vitro incubation of recombinant AtGlcAT14A
in the presence of UDP-GlcA improves the emulsifier prop-
erty of gum arabic. The in plantamodification of gum arabic
by the co- or overexpression of AtGlcAT14A would be a
useful approach to produce enzyme-modified gum arabic.
The application of genetics in acacia trees may not be an easy
solution, but Professor Kieliszewski’s group at Ohio Univer-
sity succeeded in producing a synthetic gum arabic variant
by expressing a synthetic peptide based on the sequence-
motif that was obtained from a purified gum arabic glyco-
protein in tobacco suspension BY2 cells [29–31]. The (ara-
bino)glycosylated synthetic peptide that was produced by the
action of tobacco endogenous enzymes performed equally as
or even better than commercial gum arabic at emulsifying
and stabilizing the activities of the oil-in-water emulsions
[32]. Therefore, AtGlcAT14A could be co-(over)expressed in
the BY2 lines expressing synthetic gum arabic peptide to
produce a gum arabic variant harboring extra amounts of
GlcA.
In summary, AGPs are interesting molecules because of
their importance not only in plant physiology but also as a
product, for example, gum arabic. GTs that are involved in
AGP biosynthesis have only begun to be identified and char-
acterized. Further investigations of the biosynthetic path-
way, subcellular localization, significance of protein-protein
interactions, and posttranslational modifications (phospho-
rylation) will not only strengthen our knowledge of plant
physiology but also provide important tools for making use
of the biosynthetic pathway for the production of useful
glycoconjugates, such as pharmaceuticals.
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